Correction of patient-specific induced pluripotent stem cells (iPSC) upon gene delivery through retroviral vectors offers new treatment perspectives for monogenetic diseases. Gene-modified iPSC clones ...
Human-induced pluripotent stem cells (iPSCs) can be utilized to study complex health conditions in in vitro platforms relevant to humans. It is possible to reprogram human iPSC lines from patient ...
Nicola Bevan is a manager in the BioAnalytics Applications Group (Royston, UK) of Sartorius (Göttingen, Germany). Her team is focused on the development of novel applications and delivering ...
David Christie, President and CEO of Orford, commented, "The very high gold grain results returned in the 2019 till samples have enabled Orford to vector in on more specific structural targets along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback